BR112015021001A2 - compostos antivirais - Google Patents
compostos antiviraisInfo
- Publication number
- BR112015021001A2 BR112015021001A2 BR112015021001A BR112015021001A BR112015021001A2 BR 112015021001 A2 BR112015021001 A2 BR 112015021001A2 BR 112015021001 A BR112015021001 A BR 112015021001A BR 112015021001 A BR112015021001 A BR 112015021001A BR 112015021001 A2 BR112015021001 A2 BR 112015021001A2
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- formula
- antiviral compounds
- antiviral
- variables
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
1/1 resumo “compostos antivirais” a presente invenção descreve compostos de fórmula i, em que as variáveis na fórmula i são definidas como aqui descritas. também são descritas composições farmacêuticas contendo tais compostos e métodos para a utilização dos compostos de fórmula i na prevenção ou tratamento de infecção pelo hcv.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361772936P | 2013-03-05 | 2013-03-05 | |
PCT/EP2014/054016 WO2014135472A1 (en) | 2013-03-05 | 2014-03-03 | Antiviral compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015021001A2 true BR112015021001A2 (pt) | 2017-07-18 |
Family
ID=50190454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015021001A BR112015021001A2 (pt) | 2013-03-05 | 2014-03-03 | compostos antivirais |
Country Status (10)
Country | Link |
---|---|
US (1) | US20160002180A1 (pt) |
EP (1) | EP2964626A1 (pt) |
JP (1) | JP2016510050A (pt) |
KR (1) | KR20150123917A (pt) |
CN (1) | CN105051026A (pt) |
BR (1) | BR112015021001A2 (pt) |
CA (1) | CA2900826A1 (pt) |
MX (1) | MX2015010892A (pt) |
RU (1) | RU2015136816A (pt) |
WO (1) | WO2014135472A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA52489A (fr) * | 2018-05-04 | 2021-03-10 | Inflazome Ltd | Nouveaux composés |
CN111518042B (zh) * | 2020-05-29 | 2021-07-30 | 赣南师范大学 | 一种1,2,4-三唑类化合物及其制备方法 |
CN115047117B (zh) * | 2022-07-18 | 2023-06-16 | 北京云鹏鹏程医药科技有限公司 | 一种同时测定利奈唑胺中3种遗传毒杂质的检测方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10123586A1 (de) * | 2001-05-08 | 2002-11-28 | Schering Ag | 3,5-Diamino-1,2,4-triazole als Kinase Inhibitoren |
AU2003250471A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
JP2006528617A (ja) * | 2003-07-24 | 2006-12-21 | ファーマジーン ラボラトリーズ リミテッド | 5−ht2b受容体アンタゴニスト |
US8492415B2 (en) * | 2007-07-03 | 2013-07-23 | Yale University | Azoles and related derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) in antiviral therapy (HIV) |
KR20190120430A (ko) * | 2012-01-06 | 2019-10-23 | 엘셀릭스 테라퓨틱스 인코포레이티드 | 바이구아나이드 조성물 및 대사 장애를 치료하는 방법 |
US20140010783A1 (en) * | 2012-07-06 | 2014-01-09 | Hoffmann-La Roche Inc. | Antiviral compounds |
BR112015018623A2 (pt) * | 2013-03-05 | 2017-07-18 | Hoffmann La Roche | compostos antivirais |
-
2014
- 2014-03-03 CN CN201480012399.3A patent/CN105051026A/zh active Pending
- 2014-03-03 MX MX2015010892A patent/MX2015010892A/es unknown
- 2014-03-03 RU RU2015136816A patent/RU2015136816A/ru not_active Application Discontinuation
- 2014-03-03 BR BR112015021001A patent/BR112015021001A2/pt not_active IP Right Cessation
- 2014-03-03 WO PCT/EP2014/054016 patent/WO2014135472A1/en active Application Filing
- 2014-03-03 EP EP14707401.7A patent/EP2964626A1/en not_active Withdrawn
- 2014-03-03 US US14/768,619 patent/US20160002180A1/en not_active Abandoned
- 2014-03-03 CA CA2900826A patent/CA2900826A1/en not_active Abandoned
- 2014-03-03 JP JP2015560640A patent/JP2016510050A/ja active Pending
- 2014-03-03 KR KR1020157027219A patent/KR20150123917A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20150123917A (ko) | 2015-11-04 |
JP2016510050A (ja) | 2016-04-04 |
CA2900826A1 (en) | 2014-09-12 |
RU2015136816A (ru) | 2017-04-07 |
US20160002180A1 (en) | 2016-01-07 |
EP2964626A1 (en) | 2016-01-13 |
WO2014135472A1 (en) | 2014-09-12 |
CN105051026A (zh) | 2015-11-11 |
MX2015010892A (es) | 2015-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015021429A2 (pt) | compostos antivirais | |
BR112018076534A2 (pt) | compostos heterocíclicos como imunomoduladores | |
BR112019000247A2 (pt) | derivados de 1,3-di-hidróxi-fenila úteis como imunomoduladores | |
BR112014017749A8 (pt) | Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo | |
BR112018068341A2 (pt) | 6-hidróxi-4-oxo-1,4-di-hidropirimidina-5-carboxamidas como agonistas de apj | |
EA201690979A1 (ru) | Производные азепана и способы лечения инфекций гепатита в | |
BR112015028879A2 (pt) | derivados heterocíclicos | |
BR112015022643A2 (pt) | inibidores diidro-pirrolpiridinona | |
MY177804A (en) | Hcv polymerase inhibitors | |
BR112018007395A2 (pt) | 2,4-di-hidróxi-nicotinamidas como agonistas de apj | |
BR112016014412A2 (pt) | Compostos de diaminopirimidil substituído, composições do mesmo, e métodos de tratamento com o mesmo | |
BR112016014020A8 (pt) | moduladores de tetra-hidropiridopirazinas de gpr6. | |
BR112014019990A8 (pt) | Compostos enediinos, seus conjugados e usos e métodos para esses compostos | |
BR112014008616A2 (pt) | compostos antivirais | |
PH12015502588B1 (en) | 4`-fluoro-2`-methyl substituted nucleoside derivatives | |
CY1118399T1 (el) | Ενωσεις βενζοφουρανιου για την θεραπεια μολυνσεων ιου ηπατιτιδας c | |
BR112015000011A2 (pt) | compostos de triazol como medicamentos antivirais | |
BR112018077075A2 (pt) | heterociclos de biarilmetila | |
BR112017000246A2 (pt) | composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal | |
BR112017005242A2 (pt) | composto, composição farmacêutica, e, composto para uso. | |
BR112014013972A2 (pt) | inibidores de hcv nssa | |
BR112016002638A2 (pt) | novos aza-oxo-indóis para o tratamento e profilaxia de infecção pelo virus sincicial respiratório | |
BR112015020952A2 (pt) | compostos antivirais | |
BR112014015582A2 (pt) | compostos antivirais | |
MX2018016339A (es) | Compuestos heterociclicos antiinfecciosos y sus usos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 4A ANUIDADE. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |